Humacyte, Inc

January 23, 2017

Humacyte 2016 Fierce Innovation Awards Finalist

The scoop Humacyte is a regenerative medicine company focused on vascular therapies. Yale University’s Laura Niklason cofounded Humacyte in 2004 to develop and commercialize technology to grow bioengineered blood vessels—and potentially other human tissues—in the laboratory. Humacyte CEO Carrie Cox…

Read More »
December 1, 2016

Bioengineered Vessel Evaluated in Research Study

Pulse Magazine – Vascular surgeon Michael Curi, MD, MPA, successfully implanted a bioengineered blood vessel in a 40-year-old male patient with kidney failure as part of a Phase 111 clinical research study. The surgery was performed at Newark’s University Hospital…

Read More »